|Bid||26.49 x 277800|
|Ask||23.95 x 244500|
|Day's range||24.97 - 25.25|
|52-week range||20.30 - 25.67|
|PE ratio (TTM)||25.49|
|Earnings date||12 Feb. 2018|
|Forward dividend & yield||0.26 (1.53%)|
|1y target est||18.59|
Protective gloves and clothing supplier Ansell says growth momentum from 2016/17 has continued into the first three months of the current financial year. The company has maintained its guidance for underlying earnings per share from its continuing businesses of 91 to 101 US cents in fiscal 2018. Adding the benefits so far from an ongoing share buyback, and earnings from Ansell's former condoms business before the completion of its $US600 million sale in September, total earnings per share are expected to be between 95 and 105 US cents for the year.
MELBOURNE, Australia--(BUSINESSWIRE)-- Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) is pleased to announce the VivaGel ® condom has been launched in Canada by Ansell (ASX:ANN) under the LifeStyles ® ...
Starpharma receives $3.5M R&D tax incentive refund Melbourne, Australia; 22 December 2016: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced it has received the anticipated $3.5M of R&D ...